Finance

Lists
Why is RADLY down 2,91%?
Dive Deeper
RADLY:OTCMKTS
RAIA DRAGOSIL ADR
USD 4,01
-2,91%
(-0,12) 1D
14 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RADLY...
Open
USD 4,01
High
USD 4,01
Low
USD 4,01
Mkt. cap
36,55 mjd
Avg. vol.
212,94 k
Volume
164,00
52-wk high
USD 5,34
52-wk low
USD 3,10
Beta
0,18
Shares outstanding
1,75 mjd
No. of employees
76 k
Open
USD 4,01
High
USD 4,01
Low
USD 4,01
Mkt. cap
36,55 mjd
Avg. vol.
212,94 k
Volume
164,00
52-wk high
USD 5,34
52-wk low
USD 3,10
Beta
0,18
Shares outstanding
1,75 mjd
No. of employees
76 k
News stories
From web sources and news partners
Profile
RD Saúde is the largest drugstore company in Latin America by revenue and market capitalization. With its headquarters in São Paulo, it has more than 3,000 pharmacies in Brazil with a national presence in all 27 states. The company's pharmacies are branded as Raia and Drogasil and are supplied by 14 distribution centers. The company also leads in online audience through its proprietary Raia and Drogasil mobile apps and websites, which accounted for 15.2% of 2023 retail gross revenues according to publicly filed financial statements. The company has 3.614 stores around Brazil. RD Saúde's top 3 competitors include Grupo DPSP, Pague Menos and Farmácias São João. Wikipedia
About RAIA DRAGOSIL ADR
CEORenato Cepollina Raduan
Employees75,6 k
Founded10 Nov. 2011
Headquarters-
SectorDrug
Previous reportsAll values in BRL
Loading Previous Earnings...
Revenue
Net income
All values in BRL
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
11,26 mjd
12,10 mjd
10,57 mjd
11,06 mjd
Cost of goods sold
7,95 mjd
8,54 mjd
7,17 mjd
7,36 mjd
Cost of revenue
7,95 mjd
8,54 mjd
7,17 mjd
7,36 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,58 mjd
2,82 mjd
2,75 mjd
2,85 mjd
Operating expense
2,58 mjd
2,82 mjd
2,94 mjd
2,86 mjd
Total operating expenses
10,53 mjd
11,36 mjd
10,11 mjd
10,22 mjd
Operating income
733,50 m
747,67 m
456,29 m
838,88 m
Other non operating income
-46,23 m
-62,76 m
-28,28 m
-48,97 m
EBT including unusual items
544,56 m
303,18 m
126,80 m
530,34 m
EBT excluding unusual items
427,87 m
358,24 m
129,38 m
512,80 m
Income tax expense
82,88 m
12,64 m
-20,47 m
114,08 m
Effective tax rate
15,22%
4,17%
-16,14%
21,51%
Other operating expenses
-
-
192,84 m
5,72 m
Net income
453,97 m
304,92 m
158,96 m
424,54 m
Net profit margin
4,03%
2,52%
1,50%
3,84%
Earnings per share
0,24
0,18
0,18
0,21
Interest and investment income
12,87 m
-
2,75 m
3,44 m
Interest expense
-273,30 m
-329,34 m
-301,14 m
-280,37 m
Net interest expenses
-260,44 m
-329,34 m
-298,39 m
-276,94 m
Depreciation and amortization charges
-
-
-
-
EBITDA
920,95 m
1,02 mjd
662,92 m
1,05 mjd
Gain or loss from assets sale
8,28 m
55,46 m
639,00 k
48,48 m
AI content may include mistakes. Learn more
Google-programme